CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

NEUROSCIENCE RESEARCH, published by Elsevier Ireland Ltd, is a leading journal in the field of neuroscience, with a notable reputation for disseminating high-quality research that spans a variety of topics within the discipline. With an ISSN of 0168-0102 and an E-ISSN of 1872-8111, this journal serves as a vital platform for both established researchers and emerging voices in the field. Ranking in the Q2 quartile in both Medicine and Neuroscience categories, it has been recognized as a reliable source of innovative findings since its inception in 1984, with continuous publication through 2024. Although it does not currently offer Open Access options, the journal is indexed in Scopus, holding a significant position at Rank #48/113 in General Neuroscience, reflecting its contribution to advancing the understanding of neural mechanisms across various contexts. With its address anchored in Ireland, NEUROSCIENCE RESEARCH plays an essential role in bridging scientific inquiry and practical applications, making it an indispensable resource for researchers, professionals, and students dedicated to the burgeoning field of neuroscience.

CELLULAR AND MOLECULAR NEUROBIOLOGY, published by SPRINGER/PLENUM PUBLISHERS, stands as a significant contributor to the fields of cell biology and neuroscience, holding a distinguished position in the academic community with an impact factor that places it in the Q2 category for both Cell Biology and Cellular and Molecular Neuroscience, along with Q1 in Medicine (miscellaneous). Since its inception in 1981, this journal has provided a critical platform for innovative research and thought-provoking reviews, fostering a deeper understanding of complex neurobiological mechanisms. The journal’s rigorous peer-review process ensures the publication of high-quality manuscripts that offer valuable insights into cellular processes and neural functions. With a commitment to advancing knowledge and promoting collaboration among researchers, CELLULAR AND MOLECULAR NEUROBIOLOGY remains an essential resource for professionals and students alike, looking to stay updated on the latest developments in neurobiology.

Acta Neuropathologica Communications is a distinguished open-access journal published by BMC since 2013, focusing on the rapidly advancing fields of neurology, cellular and molecular neuroscience, and pathology. Located in the United Kingdom, this journal serves as a vital platform for researchers to disseminate significant findings that enhance our understanding of neurological disorders and their underlying mechanisms. With an impressive impact factor reflected in its Q1 ranking across multiple relevant categories, including Cellular and Molecular Neuroscience, Neurology (Clinical), and Pathology and Forensic Medicine, Acta Neuropathologica Communications stands out in the academic community for its rigorous peer-review process and commitment to high-quality research. The journal’s Scopus rankings highlight its global relevance, placing it in the top percentiles among leading research publications. Researchers, professionals, and students alike are encouraged to access and contribute to this essential resource, fostering a collaborative and informed approach to tackling the complexities of neuropathology and neuroscience.

Eneurobiologia is an esteemed open-access journal published by UNIV VERACRUZANA, INST INVESTIGACIONES & EDUCACION, dedicated to advancing research in the vibrant field of neurobiology. With its launch in 2010, the journal aims to disseminate high-quality, peer-reviewed research articles that explore the complexities of neural systems, neurodevelopment, and neurodegenerative disorders. By providing a platform for both established researchers and emerging scholars, Eneurobiologia fosters interdisciplinary collaboration and knowledge exchange within the scientific community. Its open-access model ensures that valuable findings are accessible to a global audience, promoting the widespread application of neurobiological research. As a crucial resource for students, professionals, and researchers alike, Eneurobiologia plays a pivotal role in shaping the future of neurobiological studies and enhancing our understanding of the brain and nervous system.

CURRENT OPINION IN NEUROBIOLOGY, published by CURRENT BIOLOGY LTD, stands as a premier interdisciplinary journal in the field of neuroscience, specifically focusing on the latest advancements and emerging trends in neurobiology. With an impressive impact factor bolstered by its classification in Q1 in the Neuroscience (Miscellaneous) category and a notable Scopus rank of #16 out of 113 within General Neuroscience, this journal serves as an essential resource for academics, professionals, and students alike. Since its inception in 1991, CURRENT OPINION IN NEUROBIOLOGY has consistently provided insightful reviews covering various aspects of neurobiological research, thereby enhancing our understanding of complex neural processes. While the journal is not open access, it remains committed to disseminating high-quality research and fostering scholarly dialogue, making it a critical platform for those seeking to keep abreast of the dynamic developments in neuroscience.

SYNAPSE, an esteemed journal in the field of Cellular and Molecular Neuroscience, is published by Wiley and serves as a vital platform for disseminating groundbreaking research in neuroscience. Established in 1987, this journal has been pivotal in exploring the intricate mechanisms governing synaptic function and neural communication, contributing to our understanding of the nervous system. With an ISSN of 0887-4476 and an E-ISSN of 1098-2396, SYNAPSE is indexed in Scopus and currently holds a Q4 quartile ranking in its category, reflecting its niche yet significant presence within the research community. Despite its recent ranking in the 21st percentile among its peers, the journal’s commitment to quality and innovation remains unwavering. It is published from Hoboken, New Jersey, and although it is not an open-access journal, it provides invaluable insights and critical reviews that are pivotal for researchers, professionals, and students alike who seek to advance their knowledge in the dynamic field of neuroscience. Join us in contributing to the ever-evolving discourse in cellular and molecular neuroscience through SYNAPSE.

Welcome to Molecular Neurobiology, the premier journal dedicated to the exploration of the molecular mechanisms underlying nervous system function and pathophysiology. Published by Springer, this journal provides an essential platform for disseminating high-quality research in the rapidly evolving fields of Cellular and Molecular Neuroscience and Neurology, boasting an impressive impact factor that reflects its esteemed position within the academic community. With its ranking in the Q1 and Q2 quartiles for various neuroscience categories, Molecular Neurobiology stands at the forefront of groundbreaking discoveries, showcasing innovative studies that bridge basic science and clinical application. Researchers and professionals are invited to contribute to its rich portfolio, which spans from fundamental insights into cellular processes to advanced therapeutic strategies. Although Molecular Neurobiology does not operate as an Open Access journal, its influential body of work remains accessible through institutional and personal subscriptions. As we converge from 1987 to 2024, we continue to aim for excellence, seeking to catalyze progress in understanding neurological diseases and enhance the scientific dialogue within the neuroscience community.

Frontiers in Molecular Neuroscience, published by FRONTIERS MEDIA SA, is an esteemed open-access journal dedicated to advancing our understanding of the molecular mechanisms underlying neurological functions and disorders. Since its inception in 2008, the journal has established itself as a reputable source of cutting-edge research, earning a respectable Q2 ranking in both the fields of Cellular and Molecular Neuroscience and Molecular Biology as of 2023. With an ongoing commitment to fostering innovation, the journal presents a platform for researchers, professionals, and students to disseminate their findings and engage in scholarly discourse. The E-ISSN 1662-5099 ensures that research is readily accessible, facilitating the exchange of knowledge crucial to tackling the complexities of neurological conditions. Situated in Switzerland, the journal’s global reach is augmented by its open-access model, allowing for wide dissemination of critical research findings to a diverse audience. Join the vibrant community of scientists and practitioners who are shaping the future of molecular neuroscience through their contributions to this dynamic journal.

GLIA is a premier journal in the fields of Cellular and Molecular Neuroscience and Neurology, published by WILEY. With an impressive track record since its inception in 1988, GLIA has become an essential resource for researchers and professionals interested in the complexities of glial cells and their roles in the nervous system. Featuring articles that encompass a wide range of topics, from basic research to clinical implications, the journal is committed to advancing our understanding of neurological functions and disorders. Although not an open access publication, GLIA maintains its reputation with a significant impact factor, consistently ranking in the Q1 category as noted in 2023 Scopus rankings. With its comprehensive scope and high-quality peer-reviewed content, GLIA serves as a vital platform for disseminating groundbreaking research in the ever-evolving landscape of neuroscience.